Literature DB >> 31134507

Translation, cross-cultural adaptation and validation of the underactive bladder questionnaire to portuguese.

Marilia Perrelli Valença1, Jabiael Carneiro da Silva Filho2, Isabel Cristina Ramos Vieira Santos2, Adriano Almeida Calado2, David D Chancellor3, Michael B Chancellor4, Geraldo de Aguiar Cavalcanti2,5.   

Abstract

OBJECTIVE: The aim of the current study was to perform the translation, cross-cultural adaptation and validation of the Underactive Bladder Questionnaire (UAB-q).
METHODS: The study design included the Portuguese translation, cross-cultural adaptation and validation of the UAB-q in 90 patients from a urology outpatient clinic following international methodology. The psychometric properties tested were the validity, reliability, internal consistency and stability of the instrument.
RESULTS: The content validity index at the item (I-CVI) and scale level (S-CVI) were above 0.80 and did not require changes. Regarding the reliability analysis, Cronbach's alpha was 0.79. The internal consistency and the base time stability (test-retest) had excellent indexes; all were above 0.90.
CONCLUSIONS: These results indicate that the UAB-q is a valid, reproducible and reliable instrument for screening underactive bladders and is a potentially useful tool to guide health actions and improve the care of underactive patients.

Entities:  

Keywords:  Methods; Reproducibility of results; Surveys and questionnaires; Underactive bladder; Validation studies

Mesh:

Year:  2019        PMID: 31134507     DOI: 10.1007/s11255-019-02176-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  1 in total

1.  Translation and validation of the Portuguese version of the International Consultation on Incontinence Questionnaire (ICIQ) Bladder Diary.

Authors:  Ricardo Pereira E Silva; Filipe Lopes; Miguel Fernandes; Joana Polido; Carolina Ponte; André Esteves; Alan Uren; José Palma Dos Reis
Journal:  Int Urogynecol J       Date:  2022-01-11       Impact factor: 1.932

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.